Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 22, 2013 05:15 ET | Source: Genetic Technologies

Genetic Technologies Announces Financial Results for Half-Year Ended 31 December 2012

MELBOURNE, AUSTRALIA--(Marketwire - Feb 22, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) Increases in BREVAGen™ samples received demonstrate...
February 18, 2013 07:05 ET | Source: Alchemia

Alchemia Achieves $3.4 Million Quarterly Fondaparinux Profit Share

BRISBANE, AUSTRALIA--(Marketwire - Feb 18, 2013) - profit share up over 90% on last quarter market share increased to 25% from 22% cost of...
February 18, 2013 07:00 ET | Source: Alchemia

Alchemia Appoints Charles Walker as Chief Executive Officer

BRISBANE, AUSTRALIA--(Marketwire - Feb 18, 2013) - Brisbane drug discovery and development company Alchemia Limited (ASX: ACL) announced that Charles Walker has been appointed to the position of...
February 12, 2013 07:00 ET | Source: Biota Pharmaceuticals

Biota Pharmaceuticals Reports Second Quarter Financial Results and Corporate Update

ROCKVILLE, MD--(Marketwire - Feb 12, 2013) - Biota Pharmaceuticals, Inc. (NASDAQ: BOTA) LANI Influenza Program Advancing Toward Phase 2 Clinical Development ...
January 30, 2013 05:15 ET | Source: Sunshine Heart

Sunshine Heart Appoints Warren Watson to Board of Directors

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA--(Marketwire - Jan 30, 2013) - Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC) today announced that Warren Watson has been appointed to the Company's Board of...
January 29, 2013 17:52 ET | Source: Sunshine Heart

Sunshine Heart to Delist From the Australian Securities Exchange

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA--(Marketwire - Jan 29, 2013) - Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC) (Sunshine Heart) announced today that it intends to delist from the official list...
January 15, 2013 18:20 ET | Source: Sunshine Heart

Sunshine Heart Enters Into a $25 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA--(Marketwire - Jan 15, 2013) - Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC), a global medical device company focused on innovative technologies for moderate...
January 07, 2013 05:30 ET | Source: Sunshine Heart

Sunshine Heart Provides Clinical Update

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA--(Marketwire - Jan 7, 2013) - Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC) today provided the following clinical update on the progress of the C-Pulse®...
December 10, 2012 06:00 ET | Source: Genetic Technologies

Genetic Technologies Appoints Chief Executive Officer and Non-Executive Director

MELBOURNE, AUSTRALIA--(Marketwire - Dec 10, 2012) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) announced today the appointments of Ms. Alison Mew to the position of Chief Executive...
November 29, 2012 05:30 ET | Source: Genetic Technologies

Genetic Technologies Provides Update on Board and Management Changes

MELBOURNE, AUSTRALIA--(Marketwire - Nov 29, 2012) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) announced today the appointment of Dr. Mal Brandon to the position of Chairman. In...